This blog is related to the various litigations related to patents w.r.t pharma industry.
Tuesday, January 22, 2008
Barr and Ortho Women's Health & Urology in Discussions to Settle Ortho Tri Cyclen Lo Patent Litigation
Barr Pharmaceuticals, Inc. today announced that the Company is in discussions with Ortho Women's Health & Urology, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. concerning a definitive agreement to settle the outstanding patent litigation involving Ortho Women's Health & Urology's oral contraceptive product, ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol). The United States District Court for the District of New Jersey has postponed the trial date. The general terms and status of the anticipated settlement will not be disclosed by either party until a definitive agreement is reached.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment